Clinical and cost‐effectiveness of telemedicine among patients with type 2 diabetes in primary care: A systematic review and meta‐analysis
Authors' conclusion
Telemedicine was as effective as usual care in improving health outcomes of people with T2DM. They can provide a safe solution in times of rising demands for primary healthcare services, or in extreme events, like a global pandemic. More high-quality RCTs are needed on the cost evaluation of telemedicine.
Study context
- Population
- Adults with T2D in primary care; Randomized controlled trials (RCTs) published in English from inception until 31 December 2022, seven regions
- Participants
- 10,732 adults21 RCTs
- Comparison
- Telemedicine interventions vs usual care
- Outcome
- Clinical outcomes
Methodological detailsrandom-effects models
- Random-effects models
Pooled result
As reported in the abstract
MD, % (95% CI)
Telemedicinevs Usual careHbA1c; −0.88 mmol/mol
−0.08(−0.18 to 0.02)
MD, kg/m2 (95% CI)
Telemedicinevs Usual careBMI
0.51(−0.21 to 1.22)
MD, mmHg (95% CI)
Telemedicinevs Usual careSBP
−1.48(−3.22 to 0.26)
Telemedicinevs Usual careDBP
3.23(−0.89 to 7.34)
MD, mmol/L (95% CI)
Telemedicinevs Usual careHDL-C
0.01(−0.03 to 0.05)
Telemedicinevs Usual careLDL-C
0.08(−0.22 to 0.37)
Telemedicinevs Usual careTotal cholesterol
−0.10(−0.25 to 0.04)
MD, kg (95% CI)
Telemedicinevs Usual careWeight
−0.50(−1.21 to 0.21)
- Between Telemedicine and Usual care · TG; estimate outside its printed interval
- MD −0.08 mmol/L (95% CI −0.31 to −0.15)
Original publication
Clinical and cost‐effectiveness of telemedicine among patients with type 2 diabetes in primary care: A systematic review and meta‐analysis. Diabet Med. Published 23 May 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →